Organon Pharma Indonesia PT (ISX:SCPI) Revenue : Rp Mil (TTM As of . 20)

View and export this data going back to 1990. Start your Free Trial

What is Organon Pharma Indonesia PT Revenue?

Organon Pharma Indonesia PT's revenue for the three months ended in . 20 was Rp0.00 Mil. Organon Pharma Indonesia PT does not have enough years/quarters to calculate its revenue for the trailing twelve months (TTM) ended in . 20. Organon Pharma Indonesia PT's Revenue per Share for the three months ended in . 20 was Rp0.00. Organon Pharma Indonesia PT does not have enough years/quarters to calculate its Revenue per Share for the trailing twelve months (TTM) ended in . 20.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

Organon Pharma Indonesia PT Revenue Historical Data

The historical data trend for Organon Pharma Indonesia PT's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organon Pharma Indonesia PT Revenue Chart

Organon Pharma Indonesia PT Annual Data

Trend

Revenue

Organon Pharma Indonesia PT Quarterly Data

Revenue

Competitive Comparison of Organon Pharma Indonesia PT's Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Organon Pharma Indonesia PT's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Organon Pharma Indonesia PT's Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Organon Pharma Indonesia PT's Revenue distribution charts can be found below:

* The bar in red indicates where Organon Pharma Indonesia PT's Revenue falls into.

Organon Pharma Indonesia PT Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Organon Pharma Indonesia PT (ISX:SCPI) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.

Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.

Organon Pharma Indonesia PT Revenue Related Terms

Thank you for viewing the detailed overview of Organon Pharma Indonesia PT's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Organon Pharma Indonesia PT (ISX:SCPI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organon Pharma Indonesia PT (ISX:SCPI) » Definitions » Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jalan Jend Sudirman Kav 21, Sinarmas MSIG Tower, Floor 37 Unit 102 & 106, South Jakarta, IDN, 12920

Website

https://www.organon.com/indonesia

Organon Pharma Indonesia PT engages in the development, manufacture, and distribution of pharmaceutical products. It operates through manufacturing and commercial segments. Manufacturing, which generates the majority of the revenue, is engaged in pharmaceutical manufacturing.

Organon Pharma Indonesia PT (ISX:SCPI) Headlines

No Headlines